Valuation Caplin Point Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:02:20 2026-08-27 am EDT			5-day change	1st Jan Change
2,542.15 ^INR	+0.92%		-1.12%	+38.07%

Aug. 14	Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026
Aug. 12	Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	193,233	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	26.94%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	193,233	193,233	193,233
Change	-	68.55%	-12.11%	120.88%	52.16%	26.94%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	26.6x	23x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.38x	3.95x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.5x	1.5x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.71x	6.82x
EV / Revenue	0x	0x	0x	0x	0x	9.08x	7.71x	6.82x
EV / EBITDA	0x	0x	0x	0x	0x	26.1x	22.2x	19.2x
EV / EBIT	0x	0x	0x	-	0x	24.8x	20.7x	18x
EV / FCF	0x	0x	0x	0x	0x	50.9x	34.8x	34.2x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.88%	2.92%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.16%	0.16%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	95.6	110.7
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.18%	3.61%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	25,072	28,340
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,700	10,050
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,264	8,411
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,542.15	2,542.15	2,542.15
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	5/6/21	5/12/22	5/27/23	5/16/24	5/15/25	5/14/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CAPLIN POINT LABORATORIES LIMITED	31.06x	-	-	-	2.01B
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.05x	6.58x	22.81x	0.9%	47.78B
OTSUKA HOLDINGS CO., LTD.	18.65x	2.23x	10.07x	1.39%	40.3B
CIPLA LIMITED	27.3x	3.31x	17.17x	0.93%	11.88B
ZYDUS LIFESCIENCES LIMITED	27.57x	3.93x	16.31x	0.59%	12.03B
KRKA, D. D.	18.88x	3.36x	11.68x	3.82%	9.24B
GEDEON RICHTER	9.74x	2.25x	5.82x	4.44%	7.83B
ONO PHARMACEUTICAL CO., LTD.	16.23x	2.12x	6.9x	3.15%	7.34B
GLENMARK PHARMACEUTICALS LIMITED	29.66x	3.88x	18.05x	0.16%	7.21B
Average	23.79x	3.46x	13.60x	1.92%	16.18B
Weighted average by Cap.	25.60x	4.06x	15.53x	1.47%